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The Association of Stone Opacity in Plain Radiography with Percutaneous Nephrolithotomy Outcomes 
and Complications
Robab Maghsoudi, Masoud Etemadian*, Amir H Kashi, Alireza Ranjbaran
Purpose: To investigate the influence of stone opacity in plain radiography on stone free rate and complications of 
percutaneous nephrolithotomy (PCNL).
Materials and Methods: A number of 101 patients who underwent PCNL between July-September 2015 were 
prospectively included. Stone opacity was judged on preoperative plain Kidney-Ureter-Bladder X-ray. Stone free 
rate was evaluated two weeks after the operation by ultrasonography and KUB. 
Results: There were 61 patients with opaque stones and 40 patients with non-opaque stones. The age, body mass 
index, preoperative creatinine, history of stone surgery, and stone size was not statistically different between 
patients with opaque and non-opaque stones. Neither operation duration nor access numbers were statistically 
significant between opaque and non-opaque stones. The frequency of stone free patients in opaque stones and non-
opaque stones were 55/61 (90%) and 30/40 (75%) respectively (P = .04) The magnitude of hemoglobin drop in 
opaque stones and non-opaque stones were 1.9 ± 1.2 mg/dL versus 2.9 ± 1.7 mg/dL (P = .005).
Conclusion: The stone free rate is lower and the magnitude of bleeding is higher in PCNL of non-opaque stones 
when compared to opaque stones if rigid instruments are used for nephroscopy. 
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INTRODUCTION 
Percutaneous nephrolithotomy (PCNL) is the treat-ment of choice for large or otherwise complex renal or proximal ureteral stones(1). Since first de-
scribed by Fernstrom and Johannson(2), several modi-
fications have been described to improve the outcome 
of surgery or reduce its potential complications by 
optimizing its surgical steps, including patient posi-
tion, puncture of the collecting system, dilation, guid-
ance equipment, fragmentation modality, and exit 
strategy. Currently, fluoroscopic imaging is the most 
commonly used technique in PCNL for entry to the 
renal collecting system, checking for the proper place-
ment of surgical tools, and locating residual stones.(3)
The success in PCNL is recognized as stone-free rate 
(SFR) which is under influence of factors such as 
stone burden and location.(4) With the advent of retro-
grade intrarenal surgery (RIRS), alternative options are 
available for patients less likely to benefit from PCNL. 
After completion of lithotripsy in PCNL, residuals are 
checked by nephroscopic inspection and by fluoroscop-
ic imaging. Observing residual stones through fluor-
oscopy is largely dependent on the visibility of stones 
on plain radiography (namely opacity). Stone opacity 
can also affect the outcome of ancillary procedures 
like shockwave lithotripsy which are employed to treat 
PCNL residuals.(5,6) Previous reports have evaluated the 
association of computed tomography (CT) Hounsefield 
units (HU) with PCNL success and complications. Few 
studies have evaluated the association of stone opaci-
ty on KUB with PCNL success. This is important be-
cause routine preoperative evaluations before PCNL in 
many centers include intravenous pyelography without 
routine use of CT scan. Furthermore, a preoperative 
KUB is obtained in many centers on the morning of 
operation. Therefore, opacity on KUB is more readily 
available for PCNL candidates than CT Hounsefield 
units. Furthermore, the association of CT HUs with 
stone opacity on KUB is not perfect and wide apart 
cut off points have been suggested in the literature.(7,8) 
The present study aimed to determine whether stone 
opacity determined in plain KUB influenced the out-
comes and complications of the PCNL procedure to 
help make better treatment decisions before operation.
PATIENTS AND METHODS
Between July 2015 and September 2015, 101 patients 
underwent PCNL at our institution by two endourology 
fellows. PCNL is typically done in our center for renal 
stones ≥ 2 cm, smaller stones refractory to ESWL, and 
large upper ureteral stones. All data were gathered pro-
spectively. Preoperative data, operative characteristics 
and postoperative data were collected. According to our 
department protocol, every patient was evaluated before 
the procedure by urine analysis, complete blood count, 
serum creatinine level and coagulation assays. Preoper-
ative imaging studies included intravenous pyelography 
and/or abdominal CT scan. Stone burden was calculat-
ed based on stone surface area. Stones were categorized 
to opaque stones (visible on plain radiography) and 
non-opaque stones (non-visible on plain radiography).
Our protocol for PCNL was the standard prone 
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PCNL under fluoroscopic guidance as pre-
viously reported(9) and is summarized below. 
Renal access was achieved under fluoroscopic guid-
ance, preferably through the lower calyx, after injection 
of contrast medium through a 5F open-ended ureteral 
catheter placed by cystoscope. Tract dilation was per-
formed using the one-shot method, and a 30 F Amplatz 
sheath was inserted. Nephroscopy was performed by 
24F Wolf nephroscope. Pneumatic lithotripter (Swiss 
Master Lithoclast, EMS, Bern, Switzerland) was used 
for fragmentation of the calculi. Particles were extract-
ed by suction or grasper. Two or three access tracts were 
created as needed in case of large and complex stones. 
Residual stones were evaluated by fluoroscopic imaging 
and rigid nephroscopy intraoperatively. At the end of 
operation, PCNL was typically terminated without in-
sertion of nephrostomy tube (tubeless). A 4.8-F ureteral 
double-J stent was inserted for patients with a single kid-
ney, pyonephrosis, pelvicaliceal system injury or signif-
icant residual calculi. The Foley and ureteral catheters 
were removed 24 to 48 hours after the procedure. Dou-
ble-J stent was removed 2 to 4 weeks after the operation. 
All patients were evaluated 2 weeks after surgery by 
ultrasonography (US),and/or unenhanced CT scan. 
In accordance with previous reports, stone free pa-
tient was defined as the absence of residual fragments 
or observing residual fragment of < 4 mm.(10-12) Pa-
tients with residual fragments were treated with oral 
medications after receiving their stone analysis data.
Data were entered into SPSS ver. 22.0 software (Chi-
cago, IL).  Comparison of numerical data between 
the two study groups was performed by independent 
samples t-test or Mann-Whitney as appropriate. Chi-
square or fisher exact tests were used for comparison 
of categorical data across study groups. Statistical sig-
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nificance was considered at two sided P-value <.05. 
RESULTS
The mean ± SD of patients’ age was 44.9 ± 13.7 years. 
33 patients were female. History of diabetes and hyper-
tension was positive in 8 and 27 patients respectively. 
58 operations were performed on the left side. Trans-
fusion was needed in 11 operations (6 operations in 
the opaque group and 5 operations in the non-opaque 
group). Postoperative fever defined by oral T > 38°C 
for > 24 hours was observed in 5 patients (3 patients 
in the opaque group and 2 patients in the non-opaque 
group). No case of pleural or bowel injury was observed. 
Patients’ and operations’ characteristics between pa-
tients with opaque and non-opaque stones have been 
compared in Table 1.
Table 1 illustrates that the relative frequency of stone 
free patients is higher in the group of patients with opaque 
stones compared to patients with non-opaque stones.
Also, the amount of hemoglobin drop (preoperative he-
moglobin – postoperative hemoglobin) in patients with 
non-opaque stones was higher than patients with opaque 
stones. (2.9 ± 1.7 mg/dL versus 1.9 ± 1.2 mg/dL, P = .005)
DISCUSSION
Our study data simply reveals the inferior stone free 
rate of PCNL in case of non-opaque stones together 
with higher hemoglobin loss in these patients. Achiev-
ing a high stone free rate together with minimizing 
complications are the main efficacy targets for PCNL. 
Recently, the use of RIRS for renal stones has been 
reported with a high success rate sometimes equal to 
PCNL.(13-15) Therefore, it is advisable to explore fac-
tors that hamper the success of PCNL as alternative 
Table 1. Patients’ and operations’ data compared between patients with and without opaque stones.
     Opaque stones; N=61 Non-opaque stones; N=40  P value
Age,years;  mean±SD    45.0±13.5  44.8±14.3   0.94
Body mass index; mean±SD   26.9±4.4  26.8±3.8   0.93
Preop creatinine, mg/dL; mean±SD   1.3±0.2  1.3±0.2   0.67
History of PCNL or ESWL; N(%)   15 (25)  14 (35)   0.26
History of open stone surgery; N(%)   10 (16)  7 (17)   0.88
Stone surface area, cm2; mean±SD   4.7±4.2  4.8±4.2   0.95
Stone location, N(%)         0.44
Single calyx    7 (11)  5 (12) 
Pelvis     12 (20)  8 (20) 
Pelvis + single calyx    24 (39)  10 (25) 
Pelvis + ≥ 2 calices    18 (30)  17 (43) 
Operation duration, minutes; mean±SD  54±24  55±17   0.73
Pelvicaliceal system injury; N(%)   9 (15)  7 (17)   0.71
Access numbers, 1/2/3   53/5/2  35/5/0   0.57
Preop hemoglobin, mg/dL; mean±SD  13.5±1.4  13.4±1.6   0.76
Postop hemoglobin, mg/dL; mean±SD  11.5±1.6  10.5±1.4   0.001
Stone free patients, N(%)   55 (90.2)  30 (75.0)   0.04
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procedures are available in the tray of many centers. 
One study evaluated the association of CT HUs with 
SFR in PCNL.(16) They reported higher SFRs when CT 
HU exceeded 1000. SFR was lower in stones with HU 
< 1000 which includes both opaque and non-opaque 
stones in KUB. Flexible Nephroscopy was suggested 
to improve SFR in PCNL of renal stones with HU > 
677 by Gucuk et al.(17) The HU suggested by Gucuk et 
al. is very near to the cut off point for opacity of re-
nal stones in KUB that was proposed by Chua et al.(8) 
Many patients with renal stones undergo intravenous 
pyelography for preoperative evaluation as CT is not 
readily available in many countries or is expensive. 
Furthermore, a preoperative KUB is taken before the 
operation in many centers. We think that as fluorosco-
py is the most commonly employed imaging modali-
ty for PCNL for detection of residual fragments(3), the 
visibility of renal stones on fluoroscopy images can be 
more simply predicted on the preoperative KUB than 
CT images. The association of CT HUs with opacity on 
KUB has been previously investigated and reported by 
Chau et al.(7,8) In their first report, the authors suggest-
ed HU> 498 as the best cut off point for determination 
of opacity on plain KUB. In their second study, HU > 
630 was reported as the best cut off point. These cut off 
points were associated with a false negative or positive 
rate of up to 20%(7,8) simply implying the inaccuracy of 
CH HUs for determination of opacity on KUB images. 
Huang and colleagues studied ureteral stone visibility 
on plain radiography according to their characteristics 
in unenhanced CT. When the density of the stones ex-
ceeded 800 in HU standards, all ureteral stones could be 
seen, whereas only 17% of the stones could be seen on 
plain radiography when the HU level was less than 200. 
These studies point to the fact that there is no strict cut 
point according to which visibility of plain radiography 
can be estimated by CT HUs but that there is a gray zone 
in which some stones with a certain CT HU are visible 
while some are invisible on pain radiography. As previ-
ously indicated stone visibility under C-arm fluorosco-
py in PCNL operating room is under the same physics 
of visibility in KUB. Therefore; visibility of residual 
stones can be predicted more accurately by their visibil-
ity in KUB than their CT HUs. Prior studies on success in 
PCNL studies evaluated the association of success with 
CT HUs. Limited publications evaluated the success of 
PCNL with respect to stone visibility on plain KUB.(10)
The reported SFR in PCNL of non-opaque stones 
are widely different in the published series. SFRs of 
95% (for miniperc of radiolucent 1-2 cm lower cal-
iceal stones)(11), 87% (pediatric radiolucent stones)(18), 
91% (for PCNL of radiolucent 1-2 cm renal stones)
(12), and 44% (for PCNL of radiolucent stones with 
average stone surface area of 693 mm2)(10) have been 
reported in the literature. Our study data also reveals 
the inferiority of SFR in patients with non-opaque 
renal stones. Part of this difference relates to stone 
size and PCNL technique (miniperc versus standard 
PCNL) and the use of rigid versus flexible instruments.
Non-opaque stones on KUB are hard to trace in fluor-
oscopic imaging and instillation of contrast agent into 
the collecting system is employed during access phase 
of PCNL to determine the size and location of radiolu-
cent stones. The contrast agent is usually washed away 
during nephroscopy by irrigation fluid. Therefore it 
is practically improbable to detect non-opaque resid-
uals by fluoroscopy at the end of operation although 
some alternative options exist like intraoperative ultra-
sonography. Ultrasonography has long ago been used 
as a guide for access phase of PCNL operation or as 
the only method of imaging guidance in PCNL. Use 
of ultrasonography at the end of operation in case of 
radiolucent stones could probably increase stone free 
rate, however the overall sensitivity of US for detec-
tion of renal stones is in the range of 24-81% in the 
reported series(19) and lower in non-opaque stones com-
pared with opaque stones.(10) The success of intraoper-
ative ultrasonography to detect stone residuals is also 
influenced by operative factors like the shadow of ac-
cess sheath, hematoma around kidney and clots in the 
collecting system. For these reasons, to minimize the 
residue rates in patients with non-opaque renal stones, 
the routine use of flexible nephroscopy has been ad-
vocated by Gucek et al. in a randomized clinical trial. 
(17) However, flexible nephroscopy is not available in 
some PCNL centers especially in the developing world. 
Another important finding of our study was the posi-
tive correlation between stone opacity and hematocrit 
drop. We could not find previous reports on the asso-
ciation of bleeding in PCNL and stone opacity. More 
blood loss in non-opaque stones can be possibly ex-
plained by more manipulation and trauma to renal col-
lecting system or renal parenchyma on entry site while 
looking for residual fragments with a rigid nephro-
scope. Gucuk and colleagues reported more bleeding 
in case of stones with lower HUs but they used flex-
ible instruments for detection of residual fragments. 
Recent clinical trials disclosed the efficiency of RIRS 
for treatment of renal stones even when stone size is 
larger than 2 cm or the stone is in the lower pole of 
kidney with success rates close to standard PCNL.
(13-15) Few publications reported equal SFR for RIRS 
with respect to opacity.(20) Until further confirmato-
ry data will be available, we think that RIRS can be 
suggested as an alternative method for treatment 
of small-medium sized non-opaque renal stones or 
for larger stones flexible nephroscopy should be 
at hand or the patients should be consulted about a 
higher probability of residual stones when standard 
PCNL is employed with only rigid nephroscopes. 
The study limitations include failure to use flexible in-
struments as commented on in the discussion section 
which compromises generalization of results to centers 
with availability of these instruments. Furthermore, 
stone composition data was not part of the study proto-
col, therefore it was not possible to comment on the role 
of stone composition with opacity and PCNL outcomes.
CONCLUSIONS
The PCNL stone free rate in cases of radiolucent 
stones is lower and the magnitude of bleeding is 
higher if rigid instruments are used for nephroscopy. 
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